Table 2 Psychosocial, clinical and medication adherence related characteristics of respondents public Hospitals Bale zone, Southeast, Ethiopia, 2021 (n = 554)
Variables | Frequency(n = 554) | Percent (%) |
|---|---|---|
Living condition | ||
 Alone | 91 | 16.4 |
 With my wife | 276 | 49.8 |
 With family | 166 | 30 |
 Others | 21 | 3.8 |
Lost job due to HIV | ||
 Yes | 156 | 28.2 |
 No | 398 | 71.8 |
Opportunistic disease | ||
 no | 473 | 85.4 |
 Toxoplasma | 15 | 2.7 |
 Fungus | 21 | 3.8 |
 TB | 34 | 6.1 |
 Othersa | 11 | 2 |
BMI category | ||
 < 18.5 | 110 | 19.9 |
 18.5–24.99 | 395 | 71.3 |
 25–29.99 | 46 | 8.3 |
 >  = 30 | 3 | 0.5 |
Source of infection | ||
 Blood contact | 95 | 17.1 |
 Unsafe sexual intercourse | 212 | 38.3 |
 I do not know | 239 | 43.1 |
 Othersb | 8 | 1.4 |
Comorbidities | ||
 No | 480 | 86.6 |
 Diabetes mellitus | 17 | 3.1 |
 Hypertension | 27 | 4.9 |
 Othersc | 30 | 5.4 |
Substance use | ||
 Khat | 89 | 16.1 |
 Alcohol | 137 | 24.7 |
 Cigarettes | 41 | 7.4 |
 I do not use any | 287 | 51.8 |
Family member with HIV | ||
 <  = 2 | 501 | 90.4 |
 3–5 | 53 | 9.6 |
HIV related stigma | ||
 Yes | 377 | 68.1 |
 No | 177 | 31.9 |
Social support | ||
 Poor social support | 381 | 68.8 |
 Good social support | 173 | 31.2 |
WHO clinical stage | ||
 Stage I | 438 | 79.1 |
 Stage II | 68 | 12.3 |
 Stage III | 45 | 8.1 |
 Stage IV | 3 | 0.5 |
CD4 count current | ||
 < 200 | 60 | 10.8 |
 200–349 | 133 | 24 |
 350–499 | 178 | 32.1 |
 >  = 500 | 183 | 33 |
Adherence to medication | ||
 Poor adherent | 107 | 19.3 |
 Good adherent | 447 | 80.7 |
Drug side effect | ||
 Yes | 154 | 27.8 |
 No | 400 | 72.2 |
Drug regimen | ||
 First line | 447 | 80.7 |
 Second line | 107 | 19.3 |
Duration on HAART (in month) | ||
 < 12 | 16 | 2.9 |
 13–24 | 28 | 5.1 |
 >  = 25 | 510 | 92 |